Form 4: Natural Alternatives International Director Receives Stock Grant

Laura Kay Matherly, a director at Natural Alternatives International, received a grant of 8,000 shares of restricted stock on March 7, 2025.

Summary

• Laura Kay Matherly, a director at Natural Alternatives International Inc. (NAII), reported a transaction on March 7, 2025.
• She received 8,000 shares of common stock as a grant.
• The grant was made pursuant to the Issuer's 2020 Omnibus Incentive Plan.
• The restricted stock vests in three equal installments: one-third on March 7, 2026, one-third on March 7, 2027, and the final third on March 7, 2028.
• Following the transaction, Matherly directly owns 34,000 shares of Natural Alternatives International Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant is a standard practice and aligns the director's interests with shareholders. There are no immediate negative implications.

Positives

• The stock grant to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to incentivize and align their interests with shareholders.

Comparison to Industry Standards

• Stock grants to directors are a common practice, with the size and vesting schedule varying based on company size, performance, and industry standards.
• Comparable companies in the nutritional supplements industry, such as Herbalife Nutrition and USANA Health Sciences, also utilize stock-based compensation for their directors.
• The vesting schedule of one-third per year for three years is a typical vesting arrangement.

Stakeholder Impact

• The stock grant could have a slightly positive impact on shareholders by aligning the director's interests with theirs.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates